It's all sales and marketing Shell/others until information on the cell therapies is released to market.
My bet, cell therapy news will drop either "before", in anticipation of, or "after", negative PTX100/200 news. Furthermore, SYC will drop near his option exercise date.
Cynical view, yes, but SYC is a salesman, not a scientist, and past 6 months of "over promising & under delivering" do make you wonder.
I said this weeks ago, PTX price is effected by general market malaise but market is pricing negative PTX100/200 news also imho.
Thx to Eagleman calling 13c as 162% C wave length correction target, my view is under 10c, as these things tend to overcorrect one way or another.
updated chart, page-2092
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.3¢ | 4.0¢ | $32.76K | 778.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 1305968 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 596321 | 1 |
View Market Depth
| Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |